Hematology / Oncology CE Activities

Hematology / oncology blog

View Details

Targeting BCMA: A New Path in Relapsed/Refractory Multiple Myeloma

In triple- and quad-refractory myeloma, median survival was only about 9 months, and less than 6 months in penta-refractory disease.
View Details

Navigating Immunotherapy in Advanced NSCLC: What Every Oncologist Should Know

The advent of immunotherapy has significantly extended survival and revolutionized care in advanced non-small cell lung cancer (NSCLC).
View Details

Is Immunotherapy Right for Your Patient with Nonmelanoma Skin Cancer?

The primary goal of treatment in nonmelanoma skin cancer (NMSC) is tumor elimination with maximal preservation of function and cosmesis.

RMEI Presentations

RMEI DECISION SUPPORT AIDS

View Details

Intravitreal Anti-VEGF & Bispecific Therapies for DME & nAMD

In late 2022, the ocular implant, insertion tool assembly, (including the drug vial & initial fill needle) for ranibizumab PDS were voluntarily recalled due to septum dislodgement and paused implantations including ongoing global clinical trials; this did not include the refill vial and needle.
View Details

Cervical Cancer: What You Need to Know About Screening, Symptoms, and Treatments

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. An estimated 13,960 women are diagnosed with invasive cervical cancer every year.
View Details

Seeing Nonmelanoma Skin Cancers Through A New Lens: The Role and Place of Immunotherapy

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
View Details

Relapsed or Refractory Chronic-Phase: CHRONIC MYELOID LEUKEMIA (CML)

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

LATEST HEMATOLOGY / ONCOLOGY ARTICLES

RSS Latest Hematology / Oncology Articles
  • Intravenous Tenecteplase before Thrombectomy in Stroke May 21, 2025
    Among 550 patients with stroke due to large-vessel occlusion who had presented within 4.5 hours after onset, 90-day functional outcomes were better with intravenous tenecteplase before thrombectomy than with thrombectomy alone.
    Zhongming Qiu, Fengli Li, Hongfei Sang, Guangxiong Yuan, Dongjing Xie, Kai Zhou, Maohua Li, Zhaoyou Meng, Zhenyu Kong, Zhongfan Ruan, Chaoqun Li, Guangui Yang, Junxiong Wu, Chen Long, Bo Yang, Hai Hu, Yanling Li, Jun Luo, Zhonghua Shi, Xianjun Huang, Shunfu Jiang, Tingyu Yi, Guoyong Zeng, Jincheng Liu, Xiaojun Luo, Shudong Liu, Mingze Chang, Youlin Wu, Yufeng Tang, Zhenxuan Tian, Zhizhong Yan, Haojin Zhao, Yuqi Peng, Hongguo Dai, Peiyang Zhou, Huagang Li, Wenhua Liu, Dengwen Song, Bo Lei, Zhongbin Xia, Xiaolin Tan, Maojun Zhao, Xinggang Feng, Lingyu Cai, Qi Li, Yuelu Wu, Bingwu Jiang, Yan Tian, Linyu Li, Ling Jiang, Xingmin Long, Feng You, Jian Tao, Jin Zhou, Derong Wu, Chong Zheng, Congguo Yin, Duolao Wang, Mengjie Lu, Gregory W. Albers, Raul G. Nogueira, Bruce C.V. Campbell, Thanh N. Nguyen, Jeffrey L. Saver, Wenjie Zi, Qingwu Yang, the BRIDGE-TNK Trial Investigators*
  • Biopsy of Peripheral Lung Nodules — Inside Out or Outside In? May 18, 2025
    Pulmonary nodules are detected in more than 1.5 million U.S. residents every year. Nodules are identified incidentally on at least 20% of all diagnostic chest computed tomographic (CT) scans and are found even more commonly on screening low-dose CT scans. Most lung nodules are harmless. However, approximately 5% of nodules...
    Michael K. Gould
  • Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules May 18, 2025
    In this randomized trial, biopsy of indeterminate pulmonary lesions with navigational bronchoscopy was noninferior to that with transthoracic needle biopsy and led to fewer complications.
    Robert J. Lentz, Katherine Frederick-Dyer, Virginia B. Planz, Tatsuki Koyama, Matthew C. Aboudara, Sameer K. Avasarala, Jonathan D. Casey, George Z. Cheng, Pierre-François D’Haese, Jennifer D. Duke, Eric L. Grogan, Todd C. Hoopman, Joyce Johnson, James M. Katsis, Jonathan S. Kurman, See-Wei Low, Kamran Mahmood, Otis B. Rickman, Lance Roller, Cristina Salmon, Samira Shojaee, Briana Swanner, Momen M. Wahidi, Charla Walston, Gerard A. Silvestri, Lonny Yarmus, Najib M. Rahman, Fabien Maldonado, the Interventional Pulmonary Outcomes Group*

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.